Evidence map›Paper›PMID 33977722›Full record

ArticleJournal of the American Chemical Society2021

Site-Selective Chemoenzymatic Modification on the Core Fucose of an Antibody Enhances Its Fcγ Receptor Affinity and ADCC Activity.

Chao Li, Gene Chong, Guanghui Zong, David A Knorr, Stylianos Bournazos, Asaminew Haile Aytenfisu, Grace K Henry, Jeffrey V Ravetch, Alexander D MacKerell, Lai-Xi Wang

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Antibody-drug conjugate engineering: from design to efficacy and safety.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Selective fluorination of Fc glycans enhances antibody-mediated effector functions.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Glycan Remodeling Technologies for Enhancing Antibody Function.Advances in experimental medicine and biology · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Glycoengineering in antigen-specific immunotherapies.Current opinion in chemical biology · 2024
    Review
  10. Review
  11. Review
  12. Transglutaminase in Foods and Biotechnology.International journal of molecular sciences · 2023
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Chao LiDepartment of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States.ORCID 0000-0002-8090-2017
Gene ChongComputer Aided Drug Design Center, Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, United States.
Guanghui ZongDepartment of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States.ORCID 0000-0002-7335-039X
David A KnorrLaboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, New York 10065, United States.
Stylianos BournazosLaboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, New York 10065, United States.
Asaminew Haile AytenfisuComputer Aided Drug Design Center, Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, United States.
Grace K HenryDepartment of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States.
Jeffrey V RavetchLaboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, New York 10065, United States.
Alexander D MacKerellComputer Aided Drug Design Center, Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, United States.ORCID 0000-0001-8287-6804
Lai-Xi WangDepartment of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States.ORCID 0000-0003-4293-5819
University of Maryland, College Park · USRockefeller University · USUniversity of Maryland, Baltimore · US

Funding

Molecular mechanisms of antibody-mediated immunotherapiesR35CA196620 · NCI · ROCKEFELLER UNIVERSITY · PI JEFFREY Victor RAVETCH · 2016 to 2026
$11.5M
Macromolecular Conformational HeterogeneityR35GM131710 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI ALEXANDER D MACKERELL · 2019 to 2026
$6.2M
Optimization of Fc effector activity of anti-HIV antibodies to target HIV reservoirR01AI129795 · NIAID · ROCKEFELLER UNIVERSITY · PI NUSSENZWEIG, MICHEL C, RAVETCH, JEFFREY VICTOR · 2017 to 2021
$4.2M
Glycoengineering of antibodies to modulate immune functionsR01AI155716 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI LAI-XI WANG · 2020 to 2026
$3.6M
Synthesis and Function of Antibody Fc Domain GlycoformsR01GM096973 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI WANG, LAI-XI · 2011 to 2020
$2.4M
NCI NIH HHS R35 CA196620NIAID NIH HHS R01 AI129795NIAID NIH HHS R01 AI155716NIGMS NIH HHS R01 GM096973NIGMS NIH HHS R35 GM131710
6 · The paper itself

Abstract

Fc glycosylation profoundly impacts the effector functions of antibodies and often dictates an antibody's pro- or anti-inflammatory activities. It is well established that core fucosylation of the Fc domain

Indexed as

AntibodiesAntibody-Dependent Cell CytotoxicityHumansModels, MolecularReceptors, IgGAntibodiesFCGR3A protein, humanReceptors, IgG

Identifiers

PMID33977722
PMCPMC8283798
OpenAlexW3163088786

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.